プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Elsa S.に依頼

Portugal

PhD in Stem Cell Biology | 8+ years of research experience | 3+ years of drug discovery experience in industry

プロフィール概要

- PhD in Developmental and Stem Cell Biology - MSc in Molecular Oncology - BSc in Biology - 8+ years of experience in academic research (expertise in stem cell biology, cell-based assays, X-chromosome inactivation, fluorescence microscopy) - 8 publications in peer-reviewed journals - 3+ years of drug discovery experience in industry (as Senior Scientist and Business Developer) - Experienced in writing, editing and proofreading scientific works

専門分野

• ★ Cell-Based Assays
• ★ Stem Cell Research
• ★ Drug Discovery
• ☆ Molecular Biology
• ☆ Epigenetics
• ☆ PCR
• ☆ Molecular Cloning
• ☆ Gene Expression Analysis
• ☆ RNA Synthesis
• ☆ DNA/Gene Synthesis
• ☆ Cell Biology
• ☆ Microscopy
• ☆ Fluorescence Microscopy
• ☆ Cell Banking
• ☆ Cell Line Engineering
• ☆ Immunohistochemistry
• ☆ High Throughput Screening (HTS)
• ☆ Phenotypic Assays
• ☆ High Content Screening/Imaging
• ☆ Customer Service
• ☆ Project Management

サービス

• Writing
• Research
• Consulting
• Data & AI

Writing Technical Writing, General Proofreading & Editing

Research Gray Literature Search, Scientific and Technical Research, Systematic Literature Review

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis

職務経験

Business Developer

FairJourney Biologics

6月 2022 - 11月 2022

Client Manager

Charles River Laboratories

7月 2021 - 5月 2022

Senior Scientist/Scientist

Charles River Laboratories

5月 2019 - 6月 2021

Postdoctoral Research Associate

University of Cambridge

9月 2018 - 4月 2019

PhD candidate

University of Cambridge

10月 2014 - 8月 2018

学歴

PhD in Developmental and Stem Cell Biology

University of Cambridge / University of Porto

1月 2014 - 8月 2018

MSc in Molecular Oncology

University of Porto

9月 2010 - 11月 2012

BSc in Biology

University of Porto

9月 2007 - 6月 2010

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

et al., Hannah T. Stuart, Giuliano G. Stirparo, Tim Lohoff, Lawrence E. Bates, Masaki Kinoshita, Chee Y. Lim, Elsa J. Sousa, Katsiaryna Maskalenka, Aliaksandra Radzisheuskaya, Andrew A. Malcolm(2019). Distinct Molecular Trajectories Converge to Induce Naive Pluripotency . Cell Stem Cell. 25. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 388--406.e8. Elsevier {BV}

Elsa J. Sousa, Hannah T. Stuart, Lawrence E. Bates, Mohammadmersad Ghorbani, Jennifer Nichols, Sabine Dietmann, José C.R. Silva(2018). Exit from Naive Pluripotency Induces a Transient X Chromosome Inactivation-like State in Males . Cell Stem Cell. 22. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 919--928.e6. Elsevier {BV}

Daniela Barros-Silva, Pedro Costa-Pinheiro, Henrique O. Duarte, Elsa Joana Sousa, Adriane Feijó Evangelista, Inês Graça, Isa Carneiro, Ana Teresa Martins, Jorge Oliveira, André L. Carvalho, et al.(2018). MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis . Cell Death & Disease. 9. (2). Springer Science and Business Media {LLC}

Filipa Quintela Vieira, Pedro Costa-Pinheiro, Diogo Almeida-Rios, Inês Graça, Sara Monteiro-Reis, Susana Simões-Sousa, Isa Carneiro, Elsa Joana Sousa, Maria Inês Godinho, Fátima Baltazar, et al.(2015). SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3 . Oncotarget. 6. (15). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 13644--13657. Impact Journals, {LLC}

Inês Graça, Elsa J Sousa, Pedro Costa-Pinheiro, Filipa Q Vieira, Jorge Torres-Ferreira, Maria Gabriela Martins, Rui Henrique, Carmen Jerónimo(2014). Anti-neoplastic properties of hydralazine in prostate cancer . Oncotarget. 5. (15). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 5950--5964. Impact Journals, {LLC}

Elsa Sousa, Ines Graca, Tiago Baptista, Mafalda Almeida, Joao Ramalho-Carvalho, Carlos Palmeira, Rui Henrique, Carmen Jeronimo(2014). Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells . Current Pharmaceutical Design. 20. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1803--1811. Bentham Science Publishers Ltd.

Tiago Baptista, Inês Graça, Elsa J. Sousa, Ana I. Oliveira, Natália R. Costa, Pedro Costa-Pinheiro, Francisco Amado, Rui Henrique, Carmen Jerónimo(2013). Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer . Oncotarget. 4. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1673--1685. Impact Journals, {LLC}

Elsa J. Sousa, Inês Graça, Tiago Baptista, Filipa Q. Vieira, Carlos Palmeira, Rui Henrique, Carmen Jerónimo(2013). Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing . Epigenetics. 8. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 548--558. Informa {UK} Limited